摘要
目的：探析依达拉奉联合七叶皂苷钠在脑出血患者治疗中的临床有效性。方法：随机选取2015年2月至2016年2月期间我院收治脑出血患者74例，分为两组，对照组采用七叶皂苷钠治疗，试验组采用依达拉奉联合七叶皂苷钠治疗，分析两组治疗疗效。结果：试验组治疗后NIHSS评分、ADL评分、脑水肿体积、脑血肿体积程度优于对照组，P＜0.05；且试验组治疗后的总有效率高于对照组，P＜0.05。结论：依达拉奉联合七叶皂苷钠治疗脑出血的临床效果显著，可推广。
Abstract
Objective: Analysis of edaravone Aescinate sodium in the treatment of patients with intracerebral hemorrhage in clinical efficacy. Methods:in our hospital were randomly selected 74 patients with cerebral hemorrhage period from February 2015 to February 2016, divided into two groups, the control group using sodium Aescinate treatment, the test group received edaravone Sodium Aescinate analysis of the efficacy of treatment in both groups. Results:After treatment, NIHSS score, ADL score, volume of cerebral edema, cerebral hematoma volume level than the control group, P<0.05;the total efficiency of the control group, P<0.05 and the test group after treatment. Conclusion:edaravone sodium Aescinate clinical effect of cerebral hemorrhage significantly, it can be extended.
NETL
NSTL
维普
万方数据